Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
322.44
+6.90 (2.19%)
At close: Jan 9, 2026, 4:00 PM EST
322.64
+0.20 (0.06%)
After-hours: Jan 9, 2026, 7:30 PM EST
Penumbra Market Cap
Penumbra has a market cap or net worth of $12.63 billion as of January 9, 2026. Its market cap has increased by 36.78% in one year.
Market Cap
12.63B
Enterprise Value
12.37B
1-Year Change
36.78%
Ranking
Category
Stock Price
$322.44
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $12.63B, an increase of 924.71%. That is a compound annual growth rate of 25.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 12.63B | 3.71% |
| Dec 31, 2025 | 12.18B | 33.59% |
| Dec 31, 2024 | 9.11B | -6.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
| Sep 18, 2015 | 1.23B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |